Physician profile
Peter J Aronson
NPI 1952358525
$432.28
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $11.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qiagen, LLC | $247.98 | 2019 | |
| Abbvie INC. | $54.70 | 2019 | |
| Dermira, INC. | $25.77 | 2019 | |
| Ucb, INC. | $23.28 | 2019 | |
| Biofrontera INC. | $22.17 | 2019 | |
| Ethicon US, LLC | $20.98 | 2019 | |
| Tactile Systems Technology INC | $13.33 | 2019 | |
| Galderma Laboratories, L.P. | $12.54 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $11.53 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Aronson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.